The Mural Health Blog

Mural Health Technologies, Inc., a patient-first clinical trial technology company, today announced that its flagship product, Mural Link, has been selected as winner of the “Best Overall Patient Engagement Service” award in the 9th annual MedTech Breakthrough Awards program.

Read the results of Mural Health's 2025 survey of 100+ trial participants and caregivers, on their financial challenges with trial participation.

Explore the ethics of participant payments in clinical trials and learn how proper compensation can reduce barriers, support equity, and ensure compliance.

Learn how to structure participant payments in clinical trials with these seven best practices to improve compliance, retention, and ethical standards.

The clinical trial industry is shifting from incremental process improvements to foundational change. Financial workflows, participant engagement, and protocol design are no longer back-office concerns – they are now strategic levers that will determine which sponsors and CROs can run faster, more efficient, and more inclusive trials.

Read about Patient Kindness at Mural Health to learn more about why kindness and empathy in clinical research drives better study outcomes.

The Society for Clinical Research Sites (SCRS) is excited to announce Mural Health’s designation as a Global Impact Partner.

Did you know that most prepaid debit cards for clinical trial reimbursements charge participants fees? Download our eBook to learn about these fees, why they’re problematic, and what we’re doing about it!

Mural Health, a patient-first clinical trial technology company, was named "Most Innovative Start-up" at the 2024 Citeline Awards.

"The Harley Jacobsen Clinical Trial Participation Income Exemption Act"

Mural Health Announces Initiative to Eliminate Taxes on All Payments Made to Clinical Trial Participants in Order to Increase Diversity in Clinical Research

Increasing diversity within clinical trials by providing an income exclusion on all payments made to clinical trial participants.

It is critical to distinguish the girl from the voice of anorexia. Remember, the girl that you love and the anorectic brain are two different entities. She is not that monster in her head; she is captured and tormented by that monster.

“I think it's sometimes harder for the caregiver than the person in treatment. My husband loves me so much, but he can’t fix this. So he has this helpless kind of feeling."

I spent nearly 30 years as a professor and scientist in infectious and vector borne diseases. I know how to run clinical trials, as I participated in my own human studies during my years in academia.

Confronting a terminal diagnosis for your child likely is the most difficult challenge anyone will ever face. In the case of DIPG, for which there is no effective treatment and radiotherapy provides transient improvement of symptoms, clinical trials are the best option. Search for the availability and the eligibility requirements for trials specific to the disease.

“Humbling is a good word to describe all of this. When I first started chemo, my middle son was graduating from high school. ... My plan was to go to his graduation. But that day, I was really out of it. My wife said, are you ready to go?"

Clinical trial facilitator Mural Health Technologies raised $8 million in seed funding, co-CEO Sam Whitaker tells Axios exclusively.

Funding enables Mural Health to expand its Mural Link platform to modernize the clinical trial participant experience.

Mural Health has launched a non-commercial initiative to share the stories of the people who make clinical research possible.

"I was commissioned into the Army when I graduated from college. My plan was to do 20 years, retire at 42, get another job, and then eventually retire from that one. But none of that materialized."

Strategic partnership integrates next-generation patient support and payment solutions for participants and sites alike

The strategic partnership marks an important milestone for the industry as Mural Health and Clinflash platforms enable international sponsors to deliver patient payments globally, including China.

"It was a good four to six months of testing. Our second was just born when Harley’s left leg started to delay, which was almost a year to-date after two traumatic accidents the same week."

"We’ve been told several times there's no roadmap for where we're going. Brady is only the 65th documented case in the world thus far with this particular mutation." 

"Sometimes you need adversity to gain perspective. My therapist helps me remember that during these different seasons of my life, my purpose can change."

By 2027, the clinical trials software market will be worth an estimated $2.1 billion,{1} making it one of the world’s fastest growing technology sectors

Clinical ink’s Robust Clinical Trial Technology Platform adds Next Gen Patient Payment and Logistics Functionality for a Unified Patient Experience

Despite the recent shift to hybrid and decentralised clinical trials (DCT), low enrolment, poor retention, and outdated processes are still holding research back. But it’s not the technology that’s the problem – it is the way we are using it.

When myself, Jason Dong and Shawn Milochik founded Mural Health our goal was to create a next-generation clinical trial participant payments solution.

"Sometimes all you need is somebody just to be there or to make sure you are heard. My best friend came with me to every appointment. It can be hard to pay attention during appointments, especially when you’re not feeling well."

"If you’re fortunate enough to survive, what you say has more weight to it. If I could make the experience less scary for someone, I was willing to be the cancer girl."

Leading life science startups partner to deliver automated, turnkey patient payment capability to further reduce site burden and improve patient compliance

PM360 asked experts in clinical trials about the evolution of decentralized research and what areas the industry should work the hardest to improve in 2023.

As the year draws to a close, Outsourcing-Pharma caught up with some senior executives for a three-part series looking back on an eventful 2022, and look ahead to 2023.

Leading life science technology companies create integrated software solution to simplify clinical research activities and improve operational processes

Patient-centricity has become a buzzword in clinical trials, but many practical barriers still limit diversity and reduce participant satisfaction.

Mural Health Technologies, Inc., a new global provider of clinical trials technology, announced the launch of its new participant-facing technology platform, Mural Link at the CNS Summit in November.

Mural Health Technologies, Inc., a new global provider of clinical trials technology, today announced the launch of its new technology platform, Mural Link, which has been built to make it easy to be a participant in global clinical research studies.

Today, I am announcing the launch of my new tech company, Mural Health and the product platform that we have built, Mural Link.